Case 37-2012: A 21-year-old man with fevers, arthralgias, and pulmonary infiltrates

New England Journal of Medicine

Volumn 367, Issue 22, 2012, Pages 2134-2146

  Christopher Stine, Lisa ^a   Robinson, Dwight R ^b,c   Wu, Carol C ^b,c   Mark, Eugene J ^b,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AZATHIOPRINE; CETIRIZINE; ERYTHROMYCIN; GLUCOCORTICOID; IBUPROFEN; IMMUNOGLOBULIN; LEVOFLOXACIN; METHOTREXATE; OLOPATADINE; PREDNISONE; AUTOANTIBODY; LIGASE; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ACNE; ADULT; ADULT ONSET STILL DISEASE; ALLERGIC RHINITIS; ANTISYNTHETASE SYNDROME; ARTHRALGIA; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONJUNCTIVITIS; DERMATOMYOSITIS; DIFFERENTIAL DIAGNOSIS; DYSPNEA; EYE SWELLING; EYELID ERYTHEMA; FATIGUE; FEVER; HUMAN; HUMAN TISSUE; HYPERPIGMENTATION; INTERSTITIAL PNEUMONIA; IRON THERAPY; KNEE PAIN; LUNG CYST; LUNG INFECTION; LUNG INFILTRATE; MALE; MYALGIA; MYELOID METAPLASIA; NIGHT SWEAT; NOSE OBSTRUCTION; PERICARDIAL EFFUSION; PERICARDITIS; PERIORBITAL EDEMA; PRIORITY JOURNAL; PRURITUS; RHEUMATOID ARTHRITIS; RIGOR; SJOEGREN SYNDROME; SKIN BIOPSY; SYSTEMIC LUPUS ERYTHEMATOSUS; TEMPERATURE MEASUREMENT; THORAX PAIN; THORAX RADIOGRAPHY; WEIGHT REDUCTION; BLOOD; BRONCHIOLITIS; CLINICAL OBSERVATION; CLINICAL STUDY; DIAGNOSIS; EDEMA; EYELID DISEASE; IMMUNOLOGY; INTERSTITIAL LUNG DISEASE; LUNG; MYOSITIS; PATHOLOGY; RADIOGRAPHY;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ARTHRALGIA; AUTOANTIBODIES; BRONCHIOLITIS; DERMATOMYOSITIS; DIAGNOSIS, DIFFERENTIAL; EDEMA; EYELID DISEASES; FEVER; HUMANS; LIGASES; LUNG; LUNG DISEASES, INTERSTITIAL; MALE; MYOSITIS; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 84870039682     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMcpc1208147     Document Type: Article

References (38)

1. de Leon FC, Britt EJ. The noninfectious respiratory complications of infection with HIV. Curr Opin Pulm Med 1995;1:223-33.
2. Grieco MH, Chinoy-Acharya P. Lymphocytic interstitial pneumonia associated with the acquired immune deficiency syndrome. Am Rev Respir Dis 1985;131:952-5. (Pubitemid 15065934)
3. Masson C, Le Loet X, Liote F, et al. Comparative study of 6 types of criteria in adult Still's disease. J Rheumatol 1996;23:495-7. (Pubitemid 26101592)
4. Yamaguchi M, Ohta A, Tsunematsu T, et al. Preliminary criteria for classification of adult Still's disease. J Rheumatol 1992;19:424-30.
5. Ohta A, Yamaguchi M, Tsunematsu T, et al. Adult Still's disease: a multicenter survey of Japanese patients. J Rheumatol 1990;17:1058-63. (Pubitemid 20278024)
6. Shapira Y, Weinberger A, Wysenbeek AJ. Lymphadenopathy in systemic lupus erythematosus: prevalence and relation to disease manifestations. Clin Rheumatol 1996;15:335-8. (Pubitemid 26239948)
7. Eisenberg H, Dubois EL, Sherwin RP, Balchum OJ. Diffuse interstitial lung disease in systemic lupus erythematosus. Ann Intern Med 1973;79:37-45.
8. Koduri G, Norton S, Young A, et al. Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohort. Rheumatology (Oxford) 2010;49:1483-9.
9. Yoshifuji H, Fujii T, Kobayashi S, et al. Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies. Autoimmunity 2006;39:233-41. (Pubitemid 43879036)
10. Young A, Koduri G. Extra-articular manifestations and complications of rheumatoid arthritis. Best Pract Res Clin Rheumatol 2007;21:907-27. (Pubitemid 47377809)
11. Cain HC, Noble PW, Matthay RA. Pulmonary manifestations of Sjögren's syndrome. Clin Chest Med 1998;19:687-99.
12. Zimmermann C, Steiner G, Skriner K, Hassfeld W, Petera P, Smolen JS. The concurrence of rheumatoid arthritis and limited systemic sclerosis: clinical and serologic characteristics of an overlap syndrome. Arthritis Rheum 1998;41:1938-45. (Pubitemid 28506682)
13. Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med 1975;292:344-7.
14. Marguerie C, Bunn CC, Beynon HL, et al. Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes. Q J Med 1990;77:1019-38. (Pubitemid 20370993)
15. Marie I, Hatron PY, Hachulla E, Wallaert B, Michon-Pasturel U, Devulder B. Pulmonary involvement in polymyositis and in dermatomyositis. J Rheumatol 1998;25:1336-43. (Pubitemid 28312352)
16. Fiorentino D, Chung L, Zwerner J, Rosen A, Casciola-Rosen L. The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study. J Am Acad Dermatol 2011;65:25-34.
17. Mammen AL, Chung T, Christopher-Stine L, et al. Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy. Arthritis Rheum 2011;63:713-21.
18. Gunawardena H, Betteridge ZE, McHugh NJ. Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression. Rheumatology (Oxford) 2009;48:607-12.
19. Betteridge ZE, Gunawardena H, McHugh NJ. Novel autoantibodies and clinical phenotypes in adult and juvenile myositis. Arthritis Res Ther 2011;13:209.
20. Connors GR, Christopher-Stine L, Oddis CV, Danoff SK. Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years? Chest 2010;138:1464-74.
21. Mimori T, Imura Y, Nakashima R, Yoshifuji H. Autoantibodies in idiopathic inflammatory myopathy: an update on clinical and pathophysiological significance. Curr Opin Rheumatol 2007;19:523-9. (Pubitemid 47530870)
22. Targoff IN. Myositis specific autoantibodies. Curr Rheumatol Rep 2006;8:196-203. (Pubitemid 44623968)
23. Idem. Autoantibodies and their significance in myositis. Curr Rheumatol Rep 2008;10:333-40.
24. Watanabe K, Handa T, Tanizawa K, et al. Detection of antisynthetase syndrome in patients with idiopathic interstitial pneumonias. Respir Med 2011;105:1238-47.
25. Kalluri M, Sahn SA, Oddis CV, et al. Clinical profile of anti-PL-12 autoantibody: cohort study and review of the literature. Chest 2009;135:1550-6.
26. Koh WH, Dunphy J, Whyte J, Dixey J, McHugh NJ. Characterisation of anticytoplasmic antibodies and their clinical associations. Ann Rheum Dis 1995;54:269-73.
27. La Corte R, Lo Mo Naco A, Locaputo A, Dolzani F, Trotta F. In patients with antisynthetase syndrome the occurrence of anti-Ro/SSA antibodies causes a more severe interstitial lung disease. Autoimmunity 2006;39:249-53. (Pubitemid 43879038)
28. Cassidy EA, Aggarwal R, Fertig N, Lucas M, Ascherman DP, Oddis CV. Non- Jo-1 anti-synthetase autoantibodies are not specific for myositis and are associated with poor survival. Arthritis Rheum 2010;62:Suppl:929. abstract.
29. Fischer A, Swigris JJ, du Bois RM, et al. Anti-synthetase syndrome in ANA and anti-Jo-1 negative patients presenting with idiopathic interstitial pneumonia. Respir Med 2009;103:1719-24.
30. Hirakata M, Suwa A, Nagai S, et al. Anti-KS: identification of autoantibodies to asparaginyl-transfer RNA synthetase associated with interstitial lung disease. J Immunol 1999;162:2315-20. (Pubitemid 29288856)
31. Hoagland MB, Stephenson ML, Scott JF, Hecht LI, Zamecnik PC. A soluble ribonucleic acid intermediate in protein synthesis. J Biol Chem 1958;231:241-57.
32. Mehta P, Patel L, Roncaroli F, Pickering M, Brand A. Painful myositis in the antisynthetase syndrome with anti-PL12 antibodies. J Transl Med 2010;8:8.
33. Satoh S, Hirakata M, Suwa A, Mimori T, Inada S, Akizuki M. Two cases of interstitial pneumonia with anti-PL-12 (alanyl tRNA synthetase) antibodies. Ryumachi 1996;36:862-8. (In Japanese.) (Pubitemid 27097146)
34. Vega P, Ibarra M, Prestridge A, Pachman LM. Autoantibody to PL-12 (antiananyl-tRNA synthetase) in an African American girl with juvenile dermatomyositis and resolution of interstitial lung disease. J Rheumatol 2011;38:394-5.
35. Yahaba M, Suda A, Syoji R, Jujo T, Shinozaki T. A case of rapidly progressive interstitial pneumonia with anti-pL-12-antibodies successfully treated by pulse methylprednisolone and cyclophosphamide. Nihon Kokyuki Gakkai Zasshi 2008;46:547-51. (In Japanese.)
36. Handa T, Nagai S, Kawabata D, et al. Long-term clinical course of a patient with anti PL-12 antibody accompanied by interstitial pneumonia and severe pulmonary hypertension. Intern Med 2005;44:319-25. (Pubitemid 40663035)
37. Hervier B, Wallaert B, Hachulla E, et al. Clinical manifestations of anti-synthetase syndrome positive for anti-alanyl-tRNA synthetase (anti-PL12) antibodies: a retrospective study of 17 cases. Rheumatology (Oxford) 2010;49:972-6.
38. The Muscle Study Group. A randomized, pilot trial of etanercept in dermatomyositis. Ann Neurol 2011;70:427-36.